Alessandro Gronchi, MD, FSSO
Chair Sarcoma Service - Head of the Department of Surgery
Fondazione IRCCS Istituto Nazionale dei Tumori
Milano, Italy
Disclosure(s): Bayer HealthCare Pharmaceuticals Inc.: Advisor (Ongoing); Deciphera: Speaker (Ongoing); Eli Lilly & Company: Advisor (Terminated, January 1, 2020); Nanobiotix: Research Grant (Terminated, December 31, 2021); Novartis: Advisor (Terminated, November 5, 2022); pfizer: Advisor (Terminated, November 5, 2022); PharmaMar: Advisor (Ongoing), Research Grant (Ongoing); SpringWorks: Advisor (Ongoing)
Alberto Julius Alves Wainstein, MD, PhD
Professor and head of Surgical Oncology
COP, FHEMIG
BELO HORIZONTE, Minas Gerais, Brazil
Disclosure(s): No financial relationships to disclose
Christina L. Roland, MD, MS, FSSO
Associate Professor of Surgery; Chief-Saroma Surgery; Vice Chair for Research
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Disclosure(s): Bristol Myers Squibb: Research Grant (Terminated, July 31, 2021)
Steven W. Thorpe, MD
Associate Professor
University of California, Davis, California, United States
Disclosure(s): No financial relationships to disclose
Andrew J. Wagner, MD, PhD
Deputy Chief Medical Officer, Senior Physician
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Disclosure(s): Aadi Bioscience: Consultant (Ongoing), Research Grant (Ongoing); BioAlta: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing), Research Grant (Ongoing); Cogent Biosciences: Consultant (Ongoing), Research Grant (Ongoing); Daiichi-Sankyo: Consultant (Ongoing), Research Grant (Ongoing); Deciphera: Consultant (Ongoing), Research Grant (Ongoing); Eli Lilly: Consultant (Ongoing), Research Grant (Ongoing); Foghorn Therapeutics: Research Grant (Ongoing); InhibRx: Consultant (Ongoing); Karyopharm: Research Grant (Ongoing); Plexxikon: Research Grant (Ongoing); Rain Therapeutics: Research Grant (Ongoing); Servier Pharma: Consultant (Ongoing)